S&P 500
(0.11%) 5 254.35 points
Dow J
(0.12%) 39 807 points
Nasdaq
(-0.12%) 16 379 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(-0.04%) $0.926
USD/NOK
(-0.04%) $10.84
USD/GBP
(-0.15%) $0.791
USD/RUB
(-0.09%) $92.49

Realtime updates for Roquefort Therapeutics [ROQ.L]

Exchange: LSE Sector: Healthcare Industry: Biotechnology
Last Updated28 Mar 2024 @ 10:52

-3.45% £ 7.00

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 10:52):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Roquefort Therapeutics plc operates as a biotechnology research company. The company engages in the research and development of drugs targeting Midkine, a circulating growth factor protein and pro-inflammatory mediator for the treatment of cancer...

Stats
Today's Volume 359 659
Average Volume 158 288
Market Cap 9.04M
EPS £0 ( 2023-09-27 )
Next earnings date ( £0 ) 2024-06-03
Last Dividend £0 ( N/A )
Next Dividend £0 ( N/A )
P/E -3.50
ATR14 £0 (0.00%)

Roquefort Therapeutics Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Roquefort Therapeutics Financials

Annual 2022
Revenue: £0
Gross Profit: £0 (0.00 %)
EPS: £-0.0156
Q2 2023
Revenue: £200 000
Gross Profit: £198 811 (99.41 %)
EPS: £-0.00640
Q1 2023
Revenue: £100 000
Gross Profit: £100 000 (100.00 %)
EPS: £-0.00320
Q4 2022
Revenue: £0
Gross Profit: £0 (0.00 %)
EPS: £-0.00660

Financial Reports:

No articles found.

Roquefort Therapeutics

Roquefort Therapeutics plc operates as a biotechnology research company. The company engages in the research and development of drugs targeting Midkine, a circulating growth factor protein and pro-inflammatory mediator for the treatment of cancer. Roquefort Therapeutics plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators